US Bancorp’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $29.5K | Sell |
|
|||||
|
2025
Q2 | $49.9K | Sell |
|
|||||
|
2025
Q1 | $56.4K | Buy |
|
|||||
|
2024
Q4 | $32.6K | Sell |
|
|||||
|
2024
Q3 | $29.6K | Sell |
|
|||||
|
2024
Q2 | $298K | Sell |
|
|||||
|
2024
Q1 | $343K | Sell |
|
|||||
|
2023
Q4 | $427K | Buy |
|
|||||
|
2023
Q3 | $339K | Buy |
|
|||||
|
2023
Q2 | $416K | Sell |
|
|||||
|
2023
Q1 | $462K | Sell |
|
|||||
|
2022
Q4 | $463K | Sell |
|
|||||
|
2022
Q3 | $692K | Sell |
|
|||||
|
2022
Q2 | $830K | Sell |
|
|||||
|
2022
Q1 | $1.29M | Buy |
|
|||||
|
2021
Q4 | $977K | Buy |
|
|||||
|
2021
Q3 | $869K | Buy |
|
|||||
|
2021
Q2 | $834K | Buy |
|
|||||
|
2021
Q1 | $926K | Sell |
|
|||||
|
2020
Q4 | $804K | Buy |
|
|||||
|
2020
Q3 | $741K | Buy |
|
|||||
|
2020
Q2 | $504K | Buy |
|
|||||
|
2020
Q1 | $191K | Sell |
|
|||||
|
2019
Q4 | $261K | Buy |
|
|||||
|
2019
Q3 | $84K | Sell |
|
|||||
|
2019
Q2 | $190K | Buy |
|
|||||
|
2019
Q1 | $152K | Buy |
|
|||||
|
2018
Q4 | $167K | Buy |
|
|||||
|
2018
Q3 | $169K | Sell |
|
|||||
|
2018
Q2 | $194K | Buy |
|
|||||
|
2018
Q1 | $134K | Buy |
|
|||||
|
2017
Q4 | $127K | Buy |
|
|||||
|
2017
Q3 | $101K | Buy |
|
|||||
|
2017
Q2 | $117K | Sell |
|
|||||
|
2017
Q1 | $410K | Buy |
|
|||||
|
2016
Q4 | $193K | Sell |
|
|||||
|
2016
Q3 | $247K | Buy |
|
|||||
|
2016
Q2 | $169K | Buy |
|
|||||
|
2016
Q1 | $244K | Buy |
|
|||||
|
2015
Q4 | $267K | Buy |
|
|||||
|
2015
Q3 | $66K | Sell |
|
|||||
|
2015
Q2 | $133K | Sell |
|
|||||
|
2015
Q1 | $181K | Sell |
|
|||||
|
2014
Q4 | $345K | Buy |
|
|||||
|
2014
Q3 | $142K | Buy |
|
|||||
|
2014
Q2 | $68K | Buy |
|
|||||
|
2014
Q1 | $29K | Sell |
|
|||||
|
2013
Q4 | $135K | Sell |
|
|||||
|
2013
Q3 | $160K | Buy |
|
|||||
|
2013
Q2 | $59K | Buy |
|